Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1997-10-9
|
| pubmed:abstractText |
Most of these therapies, although still in the infant stages of their development, offer the potential for major advances in colorectal cancer therapy. Gene therapy is an entirely new medicinal paradigm for the treatment of cancer. Currently, the clinical application of these methods is limited by the need for a more through understanding of cancer immunology and the availability of better vector systems for efficient and selective tumor gene transfer. As increasing numbers of scientists and clinicians address these issues, better therapies will likely emerge.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0889-8588
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
795-810
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading | |
| pubmed:year |
1997
|
| pubmed:articleTitle |
Future directions for the treatment of colorectal carcinoma.
|
| pubmed:affiliation |
Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|